ASX:CSLBiotechs
Why CSL (ASX:CSL) Is Down 17.0% After Board Changes and Lowered Revenue Growth Guidance
At its October 2025 Annual General Meeting, CSL Limited announced the retirement of Dr. Megan Clark and Ms. Marie McDonald from the Board, while appointing Mr. Costa Saroukis and Mr. Gordon Naylor as new Directors effective December 1, 2025.
The leadership transition coincided with lowered revenue growth guidance for financial year 2026, signaling a period of recalibration in CSL's strategy as it aligns board expertise with shifts in the business outlook.
We'll explore how CSL's revised...